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T cells causing autoimmunity must escape tolerance.
We observed that CD8+ T cells with high avidity for
an antigen expressed in the pancreas, kidney, and thy-
micmedullawereefficiently removed fromapolyclonal
repertoire by central and peripheral tolerance mecha-
nisms. However, both mechanisms spared low-avidity
T cells from elimination. Neither the introduction of
activated, self-antigen-specific CD4+ helper T cells nor
a global inflammatory stimulus were sufficient to acti-
vate the low-avidity CD8+ T cells and did not break
tolerance. In contrast, challenge with a recombinant
bacterium expressing the self antigen primed the
low-avidity T cells, and the animals rapidly developed
autoimmune diabetes. We suggest that whereas thy-
mic and peripheral tolerance mechanisms remove
cells that can be primed by endogenous amounts of
self antigen, they do not guard against tissue destruc-
tion by low-avidity effector T cells, which have been
primed by higher amounts of self antigen or by cross-
reactive antigens.
Introduction
Negative selection of maturing thymocytes, referred
to as central tolerance, plays a key role in eliminating
autoreactive cells from the developing T cell repertoire
(Palmer, 2003; Starr et al., 2003; von Boehmer et al.,
2003). Promiscuous or ectopic expression of tissue-
restricted antigens (TRA) by medullary thymic epithelial
cells (mTECs) is crucial for central tolerance, as it pro-
vides antigens that are otherwise expressed only in
peripheral tissues (Derbinski et al., 2001; Kyewski and
Klein, 2006). The importance of promiscuous antigen ex-
pression in mTECs for establishing tolerance is under-
lined by the fact that mice and humans with defective
TRA expression by mTECs, caused by mutations in the
AIRE gene, show impaired negative selection and suffer
from multiple autoimmune disorders (Anderson et al.,
2002; Liston et al., 2004).
Most studies of central tolerance use TCR transgenic
mice, but in these models, all T cells posses receptors
with the same high affinity for a self antigen, and it is
not possible to analyze how cells bearing TCR with
lower affinity for the self antigen are dealt with. Con-
versely, due to the low frequency of cells with specificity
for a particular antigen in the endogenous repertoire,
TCR nontransgenic models allow only limited insight
into the selection process. Thus, despite the clearly
*Correspondence: mbevan@u.washington.eduestablished importance of central tolerance, it remains
unclear how efficiently negative selection removes
autoreactive T cells from the repertoire. This lack of
information is particularly true for TRA-specific T cells,
because few studies have focused on central tolerance
against such antigens (Anderson et al., 2005; Gallegos
and Bevan, 2004; Liston et al., 2003). TCR transgenic,
immature double-positive (DP) thymocytes are known
to be more sensitive than peripheral T cells in respond-
ing to peptide-MHC complexes (pMHC) that interact
weakly with the TCR (Davey et al., 1998; Lucas et al.,
1999). Furthermore, pMHC with affinities below the
threshold for activating peripheral T cells can neverthe-
less induce thymic-negative selection (Pircher et al.,
1991; Sant’Angelo and Janeway, 2002). It has therefore
been concluded that the high sensitivity of immature
thymocytes for pMHC enables central tolerance to re-
move cells carrying receptors with low affinity for self
antigens, thereby providing a safety window for self
tolerance (Knobloch et al., 1992; Pircher et al., 1991;
Sant’Angelo and Janeway, 2002). However, it remains
unclear whether this observation made with TCR trans-
genic thymocytes recognizing a widely distributed anti-
gen also holds true for a polyclonal T cell repertoire and
for the induction of central tolerance to a TRA expressed
at low levels only in the thymic medulla. In addition, be-
cause only 1%–3% of mTECs express a particular TRA
(Klein et al., 2001), the question arises whether some
self-reactive T cells might stochastically escape nega-
tive selection in the thymus (Liston et al., 2005). After T
cells leave the thymus, peripheral mechanisms of toler-
ance are also capable of eliminating TRA-specific auto-
reactive T cells (Kurts et al., 1997b; Morgan et al., 1999;
Probst et al., 2003; Redmond and Sherman, 2005), rais-
ing the question to what degree central and peripheral
mechanisms individually contribute to repertoire selec-
tion against TRA.
To analyze how efficiently central and peripheral toler-
ance mechanisms eliminate autoreactive T cells specific
for a TRA, we utilized a double transgenic mouse model.
The Rip-mOva transgene drives expression of mem-
brane bound ovalbumin in the pancreatic b cells and in
the proximal tubules of the kidney, as well as ectopically
in mTECs (Gallegos and Bevan, 2004; Kurts et al.,
1997b). The Kb-Ova epitope is constitutively crosspre-
sented by dendritic cells (DC) in the lymph nodes drain-
ing the pancreas and kidney, and this presentation
can induce peripheral tolerance when high-avidity OT-I
TCR transgenic CD8+ T cells are injected into the mice
(Kurts et al., 1997b). In the thymus of Rip-mOva mice,
ectopic expression of the Ova transgene also results in
deletion (central tolerance) of developing CD8+ and
CD4+ TCR transgenic cells (Anderson et al., 2005; Galle-
gos and Bevan, 2004). The Rip-mOva mice were crossed
to TCRb-only transgenic mice (Vb5) expressing the
same TCRb chain as OT-I that skews CD8+ T cells to rec-
ognition of the Kb-Ova ligand (Dillon et al., 1994). The
TCRb transgene, in combination with endogenously re-
arranged TCRa chains, results in a detectable polyclonal
population of CD8+ T cells with heterogeneous avidity
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262Figure 1. Tetramer Staining of Naive B6, Vb5, and Vb5xRip-mOva (C) Mice
Peripheral blood cells from B6 (A), Vb5 (B), and Vb5xRip-mOva (C) mice were stained with anti-CD8 and Kb-Ova tetramer. The representative
plots shown are gated on CD8+ T cells. The regions highlight cells staining at high and low levels with tetramer, and the numbers represent their
frequency within the CD8+ T cell population. The data are representative of three independent experiments.for Kb-Ova. Thus, we were able to visualize TRA-specific
T cells of a range of avidities in the naive repertoire and
after immunization.
By using these Vb5xRip-mOva mice, we report that
central and peripheral tolerance were equally potent in
eliminating high-avidity Kb-Ova-specific CD8+ T cells.
However, both mechanisms spared T cells with low
avidity for Kb-Ova. Interestingly, the CD8+ T cells that
escaped tolerance in Vb5xRip-mOva mice were com-
pletely refractory to priming in lymph nodes by DC
crosspresenting tissue-derived, endogenous Ova pep-
tide. Neither a strong inflammatory stimulus caused by
lymphocytic choriomeningitis virus (LCMV) or Listeria
monocytogenes (Lm) infection nor licensing of cross-
presenting DC via the introduction of Ova-specific
CD4+ T cells resulted in diabetes. In contrast, both treat-
ments led to diabetes when a small number of high-avid-
ity OT-I T cells were transferred into the mice. Despite
this failure to cause autoimmunity by relying on the
presentation of endogenous levels of Ova, infecting
Vb5xRip-mOva mice with Lm that express Ova (Lm-
Ova) resulted in rapid development of autoimmune dia-
betes caused by low-avidity effector T cells. Thus, cen-
tral and peripheral tolerance eliminated T cells that
could be primed with the endogenous level of a TRA
but did not ensure the complete elimination of all cells
that, once activated, by higher levels of self antigen or
by a mimic of the self antigen, could cause harmful auto-
immune damage.
Results
The Kb-Ova Repertoire in Naive Vb5
and Vb5xRip-mOva Mice
Functional studies showed previously that unimmu-
nized Vb5 transgenic mice on a B6 background have
a high frequency of CD8+ T cells that can respond to
the Kb-Ova epitope (Dillon et al., 1994). We originally em-
ployed tetramer staining to visualize these cells. In com-
parison to B6 mice, peripheral cells from Vb5 mice
showed a readily detectable population of CD8+ T cells
that stained brightly with Kb-Ova tetramers (Figures 1Aand 1B). In addition to this brightly staining population,
Vb5 mice contained CD8+ T cells that stained less
brightly with tetramer at levels in excess of those seen
in control B6 mice. CD8+ T cells in Vb5 mice that also
carry the Rip-mOva transgene lacked the tetramer-
bright population, but retained the increased number
of cells that stained at lower levels (Figure 1C). These re-
sults suggested that CD8+ T cells with high-avidity TCR
for Kb-Ova are largely eliminated in the double trans-
genic Vb5xRip-mOva mice, but low-avidity T cells may
still be present in these mice.
Assessing the Functional Avidity
of Ova-Specific T Cells
We devised a method to allow us to study more pre-
cisely the tetramer-dull, presumably low-avidity, T cells.
Peripheral T cells from naive mice were activated in vitro
by stimulation with anti-CD3 plus anti-CD28-coated
beads for 6 days. This led to a nonbiased, 150- to 200-
fold expansion of CD8+ T cells and the acquisition of ef-
fector function, including the ability to make IFNg after
brief peptide stimulation. Without restimulation, less
than 1% of the bead-stimulated blasts made IFNg in
quantities that could be detected by intracellular cyto-
kine staining (ICS). After short-term restimulation with
PMA plus ionomycin, however, the vast majority of cells
made cytokine (Figure 2A). The stimulation of cytokine
production by a range of concentrations of the Ova pep-
tide provided a way to measure the functional avidity
of T cells for the Kb-Ova epitope. The experiment in
Figure 2A shows a representative comparison of T cells
isolated from control B6 mice, T cells from OT-I mice
that uniformally express a high-affinity TCR, and T cells
from Vb5 and Vb5xRip-mOva mice. Even at the highest
concentration of Ova peptide, B6 T cells showed no
IFNg production above the unstimulated control, indi-
cating that the precursor frequency of Kb-Ova-specific
CD8+ T cells in these mice is below the limit of detection
of this assay. In contrast, almost all of the cells from OT-I
mice made IFNg with peptide concentration as low as
10210 M, and about half of the OT-I cells made IFNg at
10211 M Ova peptide. About 5% of T cells from Vb5
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263Figure 2. Detection of Kb-Ova-Reactive T Cells in Nonimmunized Mice
(A) Peripheral blood CD8+ T cells from OT-I, Vb5, Vb5xRip-mOva, and control B6 mice were expanded with anti-CD3 plus anti-CD28 beads.
6 days later, cells were stimulated with congenically marked splenocytes in the presence of PMA and Ionomycin, no peptide, or the indicated
concentrations of Ova257-264 peptide and analyzed for intracellular accumulation of IFNg. Representative flow data gated on expanded CD8
+
T cells are shown.
(B and C) Peptide dose-response curves graphing the mean percentage of peripheral blood CD8+ T cells in Vb5xRip-mOva, Vb5, and B6 (B) or of
CD8+ T cells isolated from pancreatic lymph nodes of Vb5xRip-mOva and Vb5 mice (C) that specifically produce IFNg in response to Ova257-264
stimulation. Bars represent standard deviation of data from 3–5 mice. Results are representative of at least three experiments.
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264Figure 3. Incidence of Autoimmune Diabetes in Vb5xRip-mOva Mice after Lm-Ova Infection
Vb5xRip-mOva mice were immunized with Listeriamonocytogenes-expressing ovalbumin (Lm-Ova) or wild-type Listeria (Lm-wt). Blood glucose
was monitored starting from day 5–7 until day 11 postinfection, and mice with levels above 300 mg/dl were considered diabetic.
(A) Maximum blood glucose levels, detected between days 5–6 and days 7–9 post Lm-Ova (triangles) infection and days 7–9 after Lm-wt
(squares) infection are shown.
(B) Representative 203 magnified, HE-stained pancreas sections of Lm-Ova-immunized Vb5xRip-mOva (left) and Vb5 (middle) mice and Lm-
wt-immunized Vb5xRip-mOva mice (right) are presented.mice, and about 4% of cells from Vb5xRip-mOva mice,
produced IFNg above background at 1025 M and 1026
M Ova peptide. The response of the Vb5 cells remained
above background levels when the peptide concentra-
tion was titered down to 10211 M, indicating the exis-
tence of cells with TCR of affinity similar to that of
OT-I. In contrast, IFNg production by the T cells from
Vb5xRip-mOva mice reached background levels at 1029
M peptide, suggesting the absence of high-avidity cells
(Figure 2A).
The raw data, obtained from several naive mice, were
corrected for background and plotted as a dose-re-
sponse curve (Figure 2B). About 1% of CD8+ T cells
from naive Vb5 mice recognized antigen with high avid-
ity and responded to 10211 M and 10210 M peptide, while
such cells were absent in Vb5xRip-mOva mice. This fre-
quency of high-avidity Kb-Ova-specific T cells is similar
to the number of tetramer-bright CD8+ T cells observed
specifically in the Vb5 mice (Figure 1B). Moreover, sort-
ing Kb-Ova tetramer-bright cells from Vb5 mice and an-
alyzing their functional avidity by ICS after expansion
with anti-CD3 plus anti-CD28 beads confirmed that the
tetramer-bright cells are the high-avidity T cells de-
tected in the ICS assay (data not shown). Starting from
a concentration of 1029 M Ova peptide, the curves for
Vb5 and Vb5xRip-mOva increased in parallel, indicating
that both types of mice contained a similar fraction of
cells recognizing Kb-Ova with low avidity, representingabout 4% of total CD8+ T cells. Because only about
1% tetramer-dull cells were observed (Figure 1), this
suggests that the ICS assay is more sensitive than tetra-
mer staining in detecting low-avidity T cells.
To ask whether high-avidity, Ova-specific T cells ac-
cumulated in lymph nodes draining the pancreas of
Vb5xRip-mOva mice, T cells were also isolated from
the pancreatic lymph nodes of naive Vb5 and Vb5xRip-
mOva mice and stimulated with anti-CD3 plus anti-
CD28 beads, and the resulting blasts were restimulated
with titered concentrations of Ova peptide. Similar to the
result with T cells isolated from spleen or blood, the pan-
creatic lymph nodes of Vb5xRip-mOva mice did not har-
bor high-avidity CD8+ T cells specific for the Ova peptide
(Figure 2C). We conclude that about 1% of CD8+ T cells
in naive Vb5 mice have high avidity for Kb-Ova, compa-
rable to that of OT-I T cells, and about 4% of cells
have a much lower avidity. In Vb5xRip-mOva mice, the
former are eliminated or silenced, but the later, low-avid-
ity CD8+ T cells are spared.
Induction of Autoimmune Diabetes
in Double Transgenic Mice
While unimmunized Vb5xRip-mOva mice do not spon-
taneously develop autoimmune diabetes, 83% of ana-
lyzed mice (20 out of 24 mice) developed diabetes be-
tween day 5 and 9 postinfection with Lm-Ova (Figures
3A and 3B). In contrast, infection with wild-type Lm
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(0 out of 8 mice). Histologically, the pancreas of Lm-Ova-
infected Vb5xRip-mOva mice showed extensive islet in-
filtration and islet destruction. In contrast, the islets of
Lm-Ova-infected Vb5 mice or Lm-wt-infected Vb5xRip-
mOva mice appeared normal (Figure 3B).
To asses whether diabetes was caused by the low-
avidity anti-Kb-Ova T cells or whether a small number
of high-avidity cells escaped tolerance and caused dis-
ease, splenocytes from Vb5xRip-mOva and Vb5 mice
were harvested on day 7 after Lm-Ova infection, imme-
diately stimulated with serial dilutions of Ova peptide,
and analyzed for their ability to make IFNg. At the max-
imum concentration of 1025 M peptide, about 5% of
total CD8+ T cells in immunized Vb5xRip-mOva mice
responded while immunized Vb5 mice contained about
four times as many responders (Figure 4A). Cells from
uninfected Vb5xRip-mOva and Vb5 mice did not pro-
duce IFNg at any concentration of peptide, indicating
that in these mice, the Kb-Ova-specific cells were naive
Figure 4. Comparison of Functional Avidity of Kb-Ova-Reactive T
Cells Found after Lm-Ova Infection in Vb5xRip-mOva and Vb5 Mice
(A) Splenocytes harvested from Vb5xRip-mOva (n = 4) and Vb5 (n = 6)
mice on day 7 post Lm-Ova infection and from unimmunized
Vb5xRip-mOva (n = 1) and Vb5 (n = 1) mice were stimulated with
the indicated concentrations of Ova peptide and analyzed for the
percentage of CD8+ T cells producing IFNg. The mean percentage
of CD8+ T cells producing IFNg is graphed against the concentration
of Ova peptide used to stimulate the cells (error bars represent stan-
dard deviation).
(B) Comparison of the functional avidity of Ova peptide-reactive T
cells found on day 7 post Lm-Ova infection in the pancreas (n = 1),
pancreatic lymph nodes (n = 1), and spleen (n = 4) of Vb5xRip-
mOva mice and in the spleen of immunized Vb5 mice (n = 6). The ex-
tent of IFNg production at a given peptide concentration is shown as
the fraction of the responses induced by 1025 M peptide. Data for
splenocytes is derived from (A). Pancreas infiltrating and pancreatic
lymph node CD8+ T cells were expanded with anti-CD3 plus anti-
CD28 for 6 days, then stimulated with congenically marked spleno-
cytes plus Ova peptide and analyzed for IFNgproduction. Shown are
mean values for the indicated number of mice used, and where
applicable bars represent standard deviation.(Figure 4A). In order to better compare the slope and
thus the functional avidity of the cells making IFNg in
the immunized mice, the data were normalized to the
response seen at 1025 M peptide (Figure 4B). This re-
vealed that about 100 times more peptide was required
to induce a half-maximal response in the effector T cells
from Lm-Ova-immunized Vb5xRip-mOva mice than
the concentration that was required for cells from Vb5
mice. Notably, as with polyclonal activation of naive
CD8+ T cells (Figure 2), T cells able to make cytokine
upon stimulation with 10211 to 10210 M peptide were ab-
sent in the double transgenic mice. It is also noteworthy
that the shape of the peptide titration curve for Lm-Ova-
immunized Vb5 mice shifted compared to the curve for
naive mice stimulated with anti-CD3 plus anti-CD28
beads, indicating a preferential enrichment of high-avid-
ity cells after immunization (compare Figure 2B with Fig-
ure 4). To ask whether CD8+ T cells with higher avidities
could be found in other organs of Vb5xRip-mOva mice,
pancreas-infiltrating T cells and T cells from pancreatic
lymph nodes from diabetic mice at day 7 postinfection
with Lm-Ova were also analyzed. Because the cell yields
from these organs were too low to allow direct analysis
in a peptide titration assay, the cells were polyclonally
expanded with anti-CD3 plus anti-CD28 beads, and
after 6 days, assessed for their functional avidity. The
avidity of the cells isolated from these organs resembled
the avidity of cells found in the spleen of the same mice,
once again revealing a deficiency of high-avidity cells
(Figure 4B). This indicates that high-avidity Kb-Ova-re-
active cells are efficiently removed from the repertoire
of Vb5xRip-mOva mice, but low-avidity T cells capable
of becoming effectors that cause autoimmunity after
Lm-Ova infection remain.
DC in the lymph nodes draining the pancreas and kid-
neys of Rip-mOva mice constitutively present the Kb-
Ova epitope to CD8+ T cells (Kurts et al., 1997b). How-
ever, this level of presentation is not sufficient to induce
diabetes when double transgenic mice were injected
with a nonspecific inflammatory stimulus such as wild-
type Lm (Figure 3) or LCMV (Table 1). In contrast, trans-
fer of as few as 5 3 104 high-affinity OT-I T cells into
Rip-mOva mice and infection with LCMV led to rapid
development of diabetes (Table 1). It should be noted
that 5 3 104 OT-I cells is far below the number of cells
that need to be transferred into Rip-mOva mice to cause
diabetes without any further manipulation (Table 1;
Kurts et al., 1997a). These data suggest strongly that
the endogenous level of Kb-Ova presentation is suffi-
cient to activate high- but not low-avidity CD8+ T cells,
when a global inflammatory stimulus is provided.
Table 1. LCMV Infection of Vb5xRip-mOva and Rip-mOva Mice
Mice Cell Transfer Treatment Diabetes Incidence
Rip-mOva 5 3 105 OT-I none 0/3
Rip-mOva 5 3 105 OT-I LCMV 9/9
Rip-mOva 5 3 104 OT-I LCMV 4/4
Rip-mOva no transfer LCMV 0/6
Vb5xRip-mOva no transfer LCMV 0/9
Mice were injected with the indicated number of OT-I T cells and
then infected with LCMV. Blood glucose levels were monitored
every other day, starting from day 5 until day 11 postinfection, and
mice with levels above 300 mg/dl were considered diabetic.
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tivating or licensing DC crosspresenting the Kb-Ova epi-
tope in the pancreatic and renal lymph nodes of Rip-
mOva mice, such that cotransfer of naive OT-II and small
numbers of OT-I T cells causes diabetes in these mice
(Kurts et al., 1997a). However, transfer of naive OT-II
CD4+ T cells into Vb5xRip-mOva mice did not lead to di-
abetes (Table 2). Furthermore, even when these mice
were subsequently injected with LPS-activated, OT-II
peptide-pulsed DC, diabetes did not result. However,
when these mice were subsequently infected with Lm-
Ova, they developed diabetes within 6–7 days. Similarly,
Vb5xRip-mOva mice remained free of disease after
injecting a large number of OT-II T cells that had been
activated in vitro with anti-CD3 plus anti-CD28 beads
(Table 2). We conclude that the double transgenic
mice do not contain CD8+ T cells that can be activated
to cause autoimmunity when relying on DC activation
and endogenous Ova presentation. Immunization with
Listeria that produce Ova, however, resulted in diabetes
caused by low-avidity CD8+ T cells.
Central and Peripheral Tolerance Spare
Lower-Avidity T Cells
Having characterized the extent to which the Kb-Ova
repertoire is shaped in Vb5xRip-mOva mice, we were in-
terested in analyzing how central and peripheral toler-
ance individually contribute to repertoire selection. To
analyze the stringency of central tolerance, we trans-
ferred thymocytes from 9-week-old Vb5xRip-mOva
or Vb5 mice into Rag12/2 hosts, infected them with
Lm-Ova, and analyzed the peptide dose response of
Kb-Ova-reactive T cells from the spleen 7 days later.
While 50% of CD8+ T cells derived from Vb5 thymocytes
produced IFNg upon restimulation with 1025 M Ova pep-
tide, only 1.5%–13% of Vb5xRip-mOva CD8+ T cells re-
sponded to this peptide concentration (data not shown).
Interestingly, the avidity spectrum of Kb-Ova-specific T
cells found after adoptive transfer of double-transgenic
thymocytes closely resembled that of T cells found in
the periphery of Vb5xRip-mOva mice (Figure 5A). Simi-
larly, as shown in Figure 4 for Lm-Ova-infected Vb5
mice, the Kb-Ova-specific response in Lm-Ova-immu-
nized Rag2/2 mice, which received Vb5 thymocytes, is
dominated by high-avidity cells. Given that high-avidity
Table 2. Licensing of Ova Crosspresenting DC
Experiment Time Point Treatment Number Diabetic
1 day 0 1.5 3 106 naive OT-II 0/4 (until day 13)
day 13 2.5 3 106 DC
(activated, OT-II
peptide pulsed)
0/4 (until day 28)
day 28 Lm-Ova infection 3/4 (until day 39)
2 day 0 2 3 106 activated OT-II 0/4 (until day 11)
day 11 Lm-Ova infection 4/4 (until day 18)
Naive OT-II T cells (experiment 1) or OT-II T cells activated for 24 hr
with anti-CD3 plus anti-CD28 (experiment 2) were adoptively trans-
ferred into double transgenic Vb5xRip-mOva mice. Starting from
day 5, blood glucose measurements were performed every other
day. In experiment 1, mice also received 2.5 3 106 CD11c+ splenic
dendritic cells on day 13, treated with LPS and OT-II peptide, and
3000 CFU Lm-Ova on day 28. Mice from experiment 2 were infected
with Lm-Ova on day 11.Kb-Ova-specific T cells are preferentially expanded after
Lm-Ova infection, the virtual absence of high-avidity T
cells in Rag12/2 mice that received thymocytes from
Vb5xRip-mOva mice demonstrated how efficiently cen-
tral tolerance alone removed high-avidity T cells. These
findings argue against leakiness in thymic selection and
illustrate how rigorously central tolerance purges the
repertoire of high-avidity T cells specific for TRA.
Although these data indicate that peripheral tolerance
does not play an obligatory role in selecting the reper-
toire of Vb5xRip-mOva mice, peripheral tolerance is im-
portant for tolerizing T cells against antigens that are
not expressed in the thymus. Thus, we were interested
in determining how stringently peripheral tolerance
might shape the T cell repertoire. CD8+ T cells from the
periphery of congenically marked Vb5 mice were trans-
ferred into either Rip-mOva mice or B6 mice. After 6
weeks the cells were reisolated, stimulated with anti-
CD3 plus CD28 beads, and analyzed for IFNg synthesis
in response to different concentrations of Ova peptide
(Figure 5B). T cells hosted in Rip-mOva mice made
IFNg only when stimulated with peptide concentrations
higher than 1029 M, whereas cells that had resided for
6 weeks in B6 mice responded to concentrations of
peptide as low as 10211 M. Thus, although both hosts
received the same T cells, high-avidity T cells were
selectively tolerized in Rip-mOva hosts. Whether the
high-avidity T cells were deleted, rendered anergic, or
silenced in some way is not known. This experiment
indicates that, in this system, peripheral tolerance is
as potent in selecting the T cell repertoire as central
tolerance and can serve as an efficient backup for in-
ducing tolerance to antigens that are not expressed
intrathymically.
Discussion
In Rip-mOva transgenic mice, where Ova is expressed
as a model TRA (Kurts et al., 1997b), central and periph-
eral tolerance mechanisms operate efficiently to delete
all CD8+ T cells with the ability to respond to low levels
of the Kb-Ova ligand. Central tolerance in this system
is mediated by mTECs directly presenting ectopically
expressed Ova and crosspresentation by DCs, when T
cells cross from the thymic cortex to the medulla (Galle-
gos and Bevan, 2004). Peripheral tolerance in this
system occurs when CD8+ T cells, with high avidity for
Kb-Ova, traffic to the lymph nodes draining the pan-
creas and kidneys. These tolerance mechanisms are ex-
tremely efficient, as indicated by the fact that we were
unable to detect any high-avidity Kb-Ova-specific T cells
in double transgenic Vb5xRip-mOva mice. This was the
case both when we examined the naive T cell repertoire
in these mice by activating T cells nonspecifically with
anti-CD3 plus anti-CD28, as well as after immunization
with Lm-Ova. However, CD8+ T cells responding to Kb-
Ova with lower avidity can be found to a similar extent
(about 4% of total T cells) in the naive T cell repertoire
of Vb5xRip-mOva and Vb5 mice, indicating that they
are largely spared from elimination in the thymus and
the periphery. These low-avidity T cells acquired effec-
tor function after Lm-Ova immunization, as demon-
strated by their ability to make IFNg upon brief in vitro re-
stimulation with high concentrations of peptide, but no
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267Figure 5. Influence of Central and Peripheral Tolerance on CD8+ T Cells Reactive to a Tissue-Restricted Antigen
(A) Thymocytes from 9-week-old Vb5xRip-mOva (n = 3) and Vb5 (n = 3) mice were adoptively transferred into Rag12/2 mice at a ratio of one thy-
mus per recipient. 24 hr later, the mice were infected with Lm-Ova, and 7 days after infection, splenocytes were harvested and analyzed for CD8+
T cells producing IFNg in response to Ova peptide. The flow cytometry plots are representative of cells stimulated with 10210 M Ova or no peptide
control. The graph shows the complete peptide titration. Bars represent standard deviation of three mice.
(B) 107 splenic Ly5.1 CD8+ T cells from Vb5 mice were adoptively transferred either into Rip-mOva (Ly5.2) transgenic mice (n = 2) or into control B6
(Ly5.2) mice (n = 2). 6 weeks later, grafted T cells were reisolated from the host spleen and expanded for 6 days with anti-CD3 plus anti-CD28
beads. After stimulation with Ova peptide-pulsed splenocytes (Ly5.2), the expanded cells were analyzed for intracellular IFNg. The flow plots
gated on Ly5.1 cells show representative stains for stimulation with 10210 M Ova or no peptide control, and the complete titration curve for
the donor cells is shown in the graph. Shown are mean values for the indicated number of mice and the bars represent the position of individual
data points. The results are representative of at least two experiments.high-avidity T cells were detectable in the spleen, pan-
creatic lymph nodes, or within the pancreas itself, even
as the mice developed diabetes. We conclude that
low-avidity CD8+ T cells with specificity for Kb-Ova
routinely escape elimination and are the mediators of
autoimmunity in this system.
Despite the constitutive presentation of Ova in the
lymph nodes draining the pancreas and kidneys and
the presence of these low-avidity T cells in the Vb5xRip-
mOva mice, neither a global inflammatory stimulus
caused by LCMV infection (Table 1) nor licensing of
the crosspresenting DC by activated OT-II helper cells
(Table 2) resulted in autoimmunity. It is noteworthy that
both treatments are capable of activating high-avidity
T cells and causing diabetes in Rip-mOva mice that
received OT-I T cells (Table 1; Kurts et al., 1997a).Thus, it appears that Vb5xRip-mOva mice are refractory
to autoimmune disease induced by endogenous levels
of self-antigen presentation. However, the Vb5xRip-
mOva mice rapidly developed disease after immuniza-
tion with Lm-Ova. One likely explanation for this is that
infection with Lm-Ova results in a higher density of Kb-
Ova presentation than can be achieved by endogenous
antigen presentation. The higher ligand density would
allow the activation of naive, low-avidity T cells that,
upon differentiation into effector cells, could recognize
and damage pancreatic b cells expressing Ova. It would
be informative to quantitate the ligand density on anti-
gen-presenting cells in uninfected and Lm-Ova-infected
Rip-mOva mice, but the staining reagent specific for this
complex is not sensitive enough for this purpose. A sec-
ond, not mutually exclusive possibility, is that Lm-Ova
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ficient stimulatory capacity to activate even the low-
avidity T cells. With stimulation of naive CD8+ T cells
as a readout, constitutive presentation of pancreas-de-
rived antigen and presentation of Lm-Ova-derived anti-
gen have both been shown to be a property of the
same CD8a DC subset (Belz et al., 2002, 2005). This
second explanation would therefore require that the
CD8a DC crosspresenting Lm-Ova-derived antigens are
somehow more stimulatory than CD8a DC in pancreatic
and renal lymph nodes crosspresenting tissue-derived
Ova, even when the latter are activated by Ova-specific
helper T cells or an inflammatory stimulus. A recent re-
port on the induction of T cell responses to melanocyte
antigens showed that melanoma tumor immunity and
autoimmunity, read out by vitiligo, could be induced in
normal mice by immunization with vectors encoding
nonmutated self-antigens (Engelhorn et al., 2006). Al-
though the mechanisms for activating these self-reac-
tive T cells are unclear, these results provide evidence
linking the induction of autoimmunity to more efficient
presentation of the self-antigens.
At first glance, our contention that large numbers of
low-avidity T cells able to inflict tissue damage escape
central tolerance induction may seem to be at odds
with studies showing that thymic-negative selection is
able to delete virtually all cells with autoimmune poten-
tial. Experiments with ‘‘altered peptide ligands,’’ vari-
ants of antigenic peptides, have shown that immature,
DP thymocytes are exquisitely sensitive to low-affinity li-
gands. They are able to respond by fluxing Ca2+ and up-
regulating CD69 in the presence of low-affinity ligands
that are unable to activate mature, single-positive T cells
bearing the same receptor (Davey et al., 1998; Lucas
et al., 1999). Also, in vivo experiments have established
that thymic-negative selection can be induced by pMHC
ligands that are of too low affinity to signal to mature T
cells, thus providing a window of safety for self tolerance
(Knobloch et al., 1992; Pircher et al., 1991; Sant’Angelo
and Janeway, 2002). In our system, we did not observe
such a broad safety window. However, these previous
studies are not in conflict with our present findings, be-
cause they all compared the sensitivity of mature T cells
with CD4+CD8+ DP thymocytes. They used systems in
which the tolerogenic ligand was widely expressed
and had access to the most immature thymocytes. In
contrast, our study used the well-characterized Rip-
mOva model for a self-antigen expressed ectopically
at low levels only in the thymic medulla and not in the
thymic cortex. As shown previously, the deletion of
OT-I thymocytes in Rip-mOva transgenic mice occurs
after positive selection of DP thymocytes, at the subse-
quent CD4+CD8lo or CD4loCD8lo stages of CD8+ T cell
maturation (Gallegos and Bevan, 2004). A comparison
of the TCR-triggering sensitivity of these late intermedi-
ates with that of mature T cells has not been performed.
Thus, different outcomes in central tolerance induction
against a ubiquitously expressed antigen versus a TRA
might be explained by a loss of sensitivity for pMHC
ligands occurring after positive selection.
As far as we could judge from the peptide titration as-
say, the efficiency of central and peripheral tolerance in-
duction of Ova-specific CD8+ T cells in Rip-mOva trans-
genic mice is about equal (Figure 5). Both mechanismseliminate CD8+ T cells able to make IFNg in response
to concentrations of Ova peptide below 1029 M. How-
ever, this equality may not apply to all examples of self
tolerance to TRA, as some self antigens may be ex-
pressed at different levels in the periphery or in the thy-
mus. The observation that peripheral tolerance can effi-
ciently delete the T cell repertoire of self-reactive T cells
is particularly relevant for tumor immunology, because
mutated or viral tumor-associated antigens may induce
similar potent tolerization of the peripheral T cell reper-
toire. Recent observations that a spontaneously arising
tumor can tolerize tumor-specific T cells provide sup-
port for this view (Willimsky and Blankenstein, 2005).
The presence of autoreactive T cells in the periphery
can, in some cases, be attributed to the lack of antigen
or epitope presentation in the thymus (Klein et al.,
2000; Morgan et al., 1999; Ohashi et al., 1991; Oldstone
et al., 1991). In line with our findings, an earlier study
showed that even when a TRA is ectopically expressed
in the thymus, self-reactive T cells may still be present in
the periphery (von Herrath et al., 1994). It was unknown
whether the escape from tolerance in these systems
was due to leakiness in central and peripheral tolerance
processes. Our data strongly argue that this is not the
case. In our TCRb chain transgenic mice with a skewed
polyclonal repertoire, we could readily quantitate num-
bers and avidity of self-reactive cells. We showed that
both tolerance mechanisms efficiently removed all
high-avidity T cells, while they spared cells below a cer-
tain avidity threshold. Thus, mice expressing the TRA
contained just as many low-avidity self-reactive T cells
as mice that did not express the antigen, amounting in
both cases to about 4% of total CD8+ T cells. Our data
indicate that these low-avidity T cells, induced to effec-
tor activity by Lm-Ova immunization, are the causative
agents of autoimmunity. Thus, we conclude that low-
avidity T cells, although harboring self-destructive po-
tential, might routinely escape central and peripheral
mechanisms of tolerance.
In applying our findings to autoimmunity in general,
we have to ask how low-avidity autoreactive T cells
are induced to cause disease. We do not envisage that
a viral or bacterial pathogen breaks tolerance by intro-
ducing an exact copy of the self peptide. As the affinity
of the foreign pMHC-TCR interaction has been shown
to be crucial for inducing autoimmunity (Gronski et al.,
2004), we rather consider that these low-avidity anti-
self T cells have TCR with high affinity for unknown for-
eign ligands and can be readily induced when the for-
eign ligand is introduced by infection. Molecular mimicry
is one mechanism for how pathogens might trigger
autoimmune responses (Oldstone, 1998). We propose
that while self-reactive T cells that can be primed with
endogenous levels of a self-antigen are completely elim-
inated by both peripheral and central tolerance, remain-
ing low-avidity cells constitute a population of cells that
can be activated by a crossreactive foreign antigen to
cause autoimmunity. In conclusion, our findings imply
that central and peripheral repertoire selection against
TRA imposes a degree of safety that guards against
priming with endogenous self-antigen but does not fully
protect against tissue destruction when low-avidity
anti-self T cells are induced to became effector cells by
foreign antigen stimulation.
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Mice
Rip-mOva mice, expressing a membrane bound form of ovalbumin
under the control of the rat insulin promoter (Kurts et al., 1996),
Vb5 TCRb chain-only transgenic mice (Fink et al., 1992), Vb5xRip-
mOva, Rag12/2-deficient, OT-I, and OT-II TCR transgenic mice rec-
ognizing Kb-Ova257-264 and A
b/Ova323-337, respectively, as well as B6
and CD45.1 congenic B6 mice were bred and maintained in SPF
facilities at the University of Washington and used at 5–8 weeks of
age. All experiments with mice were performed in compliance with
the University of Washington Institutional Animal Care and Use
Committee regulations.
Listeria monocytogenes and LCMV Infections
Recombinant Listeria monocytogenes secreting ovalbumin (Lm-
Ova) was provided by H. Shen (University of Pennsylvania School
of Medicine, Philadelphia, PA) (Pope et al., 2001). Frozen stocks of
Lm-Ova and wild-type Listeria monocytogenes (Lm-wt) were grown
in brain-heart infusion broth to mid log phase. Cell numbers were
determined by measuring the OD at 600 nm, and 3000 CFU were
injected in PBS intravenously. LCMV Armstrong (clone 53b) was
grown on BHK cells and titered on vero cells. Frozen stocks were di-
luted in PBS and injected at 33 105 PFU per mouse intraperitoneally.
Blood Glucose Measurement and Histology
Blood was analyzed with OneTouchUltra blood glucose testing sys-
tem (Lifescan, Miltipas, CA). Values above 300 mg/dl were consid-
ered diabetic. Mice were monitored for blood glucose levels every
other day starting from day 5 or 6 (in some experiments starting
from day 7) until, if not stated otherwise, day 11 postinfection or
cell transfer. Pancreatic tissue isolated on day 7 post Lm-Ova infec-
tion was formalin fixed and sent to Histology Consultation Services
(Everson, WA) for processing and HE staining.
Cell Isolation
Single-cell suspensions from spleen, thymus, and pancreatic lymph
nodes were obtained by mashing organs through a 100 mM nylon cell
strainer (BD Falcon, Bedford, MA). Red blood cells were eliminated
from splenocytes with ACK lysis buffer. Mouse CD4+ or CD8+ T cell
Isolation kit and LS separation columns (Miltenyi Biotec, Bergisch
Gladbach, Germany) were used, according to the manufacturer’s
protocols, for untouched CD4+ or CD8+ T cell isolation from total
splenocytes. For isolation of peripheral blood-derived CD8+ T cells,
PBMC were purified from blood with lympholyte (Cedarlane Lab-
oratories, Burlington, NC) density gradient centrifugation, and un-
touched CD8+ isolation was performed with MS separation columns
(Miltenyi). Pancreas-infiltrating T cells were purified as described
(Trembleau et al., 1999). Pancreatic tissue was harvested on day 7
post Lm-Ova, minced with a scalpel, and stirred for 10 min at 37C
in HBSS (Invitrogen, Grand Island, NY) supplemented with collage-
nase 4 at 1 mg/ml (Sigma, St. Louis, MO). Nondigested tissue was
allowed to settle for 2 min, and then 2/3 of the supernatant was
replaced with fresh HBSS and collagenase. The procedure was re-
peated two more times. The supernatants were diluted in 10%
DMEM (Invitrogen), and T cells were isolated with anti-CD8 beads
and MS separation columns (Miltenyi). Dendritic cells were isolated
from the spleen as described (den Haan and Bevan, 2002) by means
of combined digestion with 1 WU/ml liberase R1 and 50 mg/ml
DNAase1 (Roche Diagnostics, Indianapolis, IN) and anti-CD11c-
based magnetic cell separation (Miltenyi).
T Cell Stimulation and Expansion
2–5 3 105 CD8+ T cells were stimulated in 48-well plates with 10 ml
anti-CD3 plus anti-CD28-coated beads (Dynal Biotech, Oslo, Nor-
way) in RPMI (Invitrogen) supplemented with 10% FCS, antibiotics,
50 mM 2-ME, and T cell growth factor (a-methylmannopyranoside-
blocked supernatant from concavalin A-stimulated rat splenocytes).
Cells were diluted 1:3 to 1:5 on day 2, 3, and 5 and analyzed for
Kb-Ova-specific T cells on day 6.
Adoptive Transfer of T Cells, Thymocytes, and Dendritic Cells
107 CD45.1 congenically marked CD8+ T cells from Vb5 mice were
injected into B6 and Rip-mOva CD45.2 host mice. 6 weeks later,cells were reisolated from the host spleen via magnetic depletion
of host-derived CD45.2 cells, expanded with anti-CD3 plus anti-
CD28 beads for 6 days, and analyzed for Kb-Ova-specific T cells.
Total thymocytes from 9-week-old Vb5 or Vb5xRip-mOva mice, at
a ratio of one thymus per mouse, were injected into Rag12/2 mice.
24 hr after the transfer, mice were infected with Lm-Ova, and spleno-
cytes from these mice were analyzed 7 days post Lm-Ova infec-
tion. Isolated DC were treated for 1 hr with 20 mg/ml of OVA323-337
peptide and 1 mg/ml LPS and then injected at 2.5 3 106 per mouse
subcutaneously.
Detection of Kb-Ova-Specific T Cells
Total peripheral blood cells were stained for 2 hr with Kb-Ova257-264
phycoerythrin-labeled tetramers in the presence of anti-CD8 PerCP
clone 53-6.7 (BD, San Diego, CA) at 4C. For measuring Kb-Ova-spe-
cific T cells by intracellular cytokine staining (ICS), either 3 3 106
splenocytes from naive or infected mice (day 7 postinfection) or
1–1.5 3 106 expanded CD8+ T cells mixed with 1.5–2 3 106 stimula-
tor cells (total splenocytes from naive CD45 congenic mice) were
transferred into 96-well plates in DMEM medium (Invitrogen) con-
taining 10% FCS, antibiotics, and 50 mM 2-ME. Ova257-264 SIINFEKL
peptide dilutions were added and the samples were incubated at
37C. Samples stimulated with 0.66 mg/ml PMA (Sigma) and
0.66 mg/ml Ionomycin (Calbiochem, San Diego, CA) served as posi-
tive controls. 45 min after adding peptide, the samples were supple-
mented with 7 mg/ml Brefeldin A (Sigma) and incubated for an addi-
tional 5.5 hr. Then samples were washed, stained with anti-CD8 and
anti-CD45.1 or anti-CD45.2 (all BD), fixed and permeabilized with
Cytofix and Cytoperm Kit (BD), and stained intracellularly with
anti-IFNg (BD).
Data Analysis
Flow cytometry data were acquired on a FACS-Canto machine (BD)
and analyzed with FlowJo software (Tree Star Inc, Ashland, OR). All
intracellular IFNg measurements were performed in duplicate. The
percentage of cells specifically producing IFNg was determined by
subtracting the response seen with the no peptide control from
the percentage of IFNg+CD8+ T cell at a given peptide concentration.
Graphs were prepared with GraphPad Prizm 3.0, and they show av-
erage data and corresponding standard deviation. When indicated,
data were normalized to the response seen at 1025 M peptide.
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